Please Note: This trial is no longer enrolling new participants
A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH OR WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA
Protocol No. | CTO-CO44668 | Scope | National |
---|---|---|---|
Principal Investigator | Anita Turk | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase III |